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INTRODUCTION
The STEP UP consortium and the High Impact Practices (HIP) initiative, together with other
partners, are supporting three consultation meetings to inform use of appropriate standards of
evidence for recommending best practices in reproductive health (RH). The first consultation
(held on 18–19 June 2013 in New York, USA) focused on the generation and synthesis of
evidence that can inform the production of HIP briefing documents. These documents describe
service delivery and enabling environment practices that, if fully implemented, will maximise
investments in a comprehensive family planning (FP) strategy. The report is available here.
The second consultation (held on 18-19 September 2013 in Croydon, UK) built on issues
discussed during the first consultation by focussing on the generation and synthesis of evidence
for practice recommendations. This meeting brought together researchers and research funders
to review the research designs and methodologies that can be used to generate evidence on the
impact of FP/RH interventions and on their implementation, the mechanisms and structures
through which such evidence is reviewed and translated into recommendations, and the
implications for organizing and funding evidence generation to maximise its quality and utility.
The third consultation, which will be held during the second quarter of 2014 in Nairobi, Kenya, will
focus on communicating and using practice recommendations.

Overview of the consultation
Thirty-seven researchers and research funders participated in the two-day meeting, which
combined panel presentations with group discussions that proposed various ways to improve
evidence to inform RH/FP programming and policy. The objectives for this consultation were:
1. Suggestions for designing implementation research to maximise the quality of evidence
generated and its utility for decision-making to strengthen reproductive health practices.
2. Recommendations for synthesising and grading bodies of evidence on a) reproductive
health service delivery, and b) other health system building blocks to improve reproductive
health services.
3. Proposals to guide appropriate funding and research implementation structures and
procedures to generate strong evidence for practice recommendations in reproductive
health.
The meeting provided a forum to present and discuss a wide range of perspectives. Agreement
was reached that a consensus was unlikely – and probably unnecessary given the many differing
evidence needs of decision-makers, the critical role of context in framing the application of
evidence, the complexity of most FP/RH interventions, and the challenges in ensuring that an
intervention is implemented at scale in the same way as it was designed and evaluated during
pilot-testing. Meeting participant discussed the complexity of evidence generation and synthesis
for identifying evidence-based practices in FP/RH and valued the opportunity to learn from a
highly experienced group of participants.
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HIGHLIGHTS
The meeting began with an overview of the HIP initiative, which identifies and generates a strong
evidence base for service delivery and enabling environment practices that are most likely to
support a FP/RH programme in achieving high impact (defined as improved health behaviours
and/or outcomes). Depending on the strength of evidence available, HIPs are categorised as
proven, promising, or emerging. Five challenges to determining the standards of evidence for
guiding FP/RH programming were identified during the first consultation [Shawn Malarcher]: 1)
research on FP lacks a common language; 2) there are no absolute agreed outcome measures;
3) strength of evidence varies greatly; 4) contexts are varied and complex; and 5) insufficient
lessons are learnt from failures.
Angela Baschieri described DFID’s multifaceted approach to generating and using evidence
throughout its policy and programming cycle. Strategies include an ‘Evidence into Action’ team,
commissioning evidence products (e.g. systematic reviews, rapid reviews, literature reviews,
evidence papers), a policy research fund, several research programme consortia (e.g. STEP UP),
a maternal health platform, and core funding for WHO’s Human Reproduction Programme.
DFID’s ‘Framework for Results’ for improving reproductive, maternal, and newborn health in the
developing world was informed by numerous evidence products to determine which
implementation strategies represented the best value for money (VfM).
John Cleland highlighted several differences between research on FP/RH interventions and on
disease/death prevention interventions: the efficacy, effectiveness, and safety of contraceptive
products are well established; FP/RH research is primarily focused on optimizing supply and
demand interventions; intensity of demand varies widely, whereas disease/death prevention is
universal; evidence is largely derived from observational studies with relatively few experimental
studies [see Mwaikambo et al. for a review]; and programming is informed more by accumulated
experience and evidence of implementation than by systematic reviews or randomised controlled
trials (RCTs). Cleland concluded by identifying common weaknesses in FP/RH evaluation
designs and recommended that future FP/RH research should seek to use quasi-experimental or
experimental designs when possible, take advantage of strengthened monitoring and evaluation
(M&E), include economic evaluations, and be implemented through closer collaboration between
implementers and researchers.

Types of design and quality of eviden ce generated
Karen Hardee provided an overview of systems used to rate the strength of evidence that informs
decision-making. Hierarchies for rating evidence have predominated in healthcare decisionmaking, drawing primarily from Gray’s rating which ranks evidence from systematic reviews of
RCTs as strong and evidence from quasi-experimental and non-experimental studies as weak.
These hierarchies, designed originally for clinical practice, have been developed to rate evidence
of intervention effectiveness. The challenges of interpreting evidence that is rated as ‘weak’ were
discussed extensively, especially as related to recommending interventions for FP/RH
programming. The limitations of this hierarchy in rating evidence to inform research questions
other than intervention effectiveness (e.g. intervention implementation, salience, acceptability,
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etc.) were discussed, and an alternative typology was presented [Petticrew & Roberts] that rates
evidence according to the type of question it is being used to inform.
James Hargreaves started his presentation from the premise that randomised trials are the most
efficient and simplest to understand design option for addressing questions about impact and
effectiveness. However, they are not always feasible and may be inappropriate for other types of
questions. Alternative designs were discussed (e.g. pragmatic randomisation, process evaluation,
stepped wedge/phased implementation, randomised ‘encouragement’ to perform an intervention,
interrupted time series, and systematic non-random allocation with regression discontinuity), with
examples provided for illustration.
Many FP/RH interventions are multi-faceted because they need to intervene at multiple levels in a
causal chain, operating through distal causes and affecting distal outcomes [Campbell]. However,
evaluation of complex interventions using RCTs is difficult for many reasons and thus is usually
not an appropriate design. An additional alternative to those described by Hargreaves is to
strengthen data collection to measure outputs and, if possible, outcomes through an M&E system
designed for an FP/RH intervention implemented at scale in different settings and populations
and with variations in the intervention design. Such data can provide an understanding of how the
intervention functions in ‘real life’; however, the M&E system must be able to measure outcomes
as well as inputs, process, and outputs. Doing so can be challenging as most M&E systems do
not collect population-level data. This evaluation approach is dependent on a well-constructed
and clearly understandable theory of change [Vogel, I.] that explains how the intervention is
meant to work, its purpose and goal, and the assumptions underlying the causal pathways that
translate implementation into outputs and outcomes.
Theories of change are often not specified in sufficient detail prior to implementing an intervention,
and/or there may be different understandings among implementers, researchers, and funders of
how an intervention is meant to work and its purpose. A case study of a theory of change for
evaluating a safe abortion intervention in India was presented by Carine Ronsmans. Intervention
implementers are trying to maximise the programme’s outputs; evaluators are seeking to
maximise attribution of the observed outcomes to the programme; and the funder wants both.
Tensions can emerge as a result of unclear expectations; for example, implementers may want to
introduce the intervention into locations most likely to serve the largest population so as to
maximise outputs, while evaluators would prefer to randomise placement of the intervention to
maximise validity of the findings. A well-constructed theory of change should clarify to
implementers, funders, and evaluators which questions a research study or evaluation can and
cannot answer and enable the perspectives of each group to be considered jointly to permit
consensus on intervention and research designs.
Ulla Kou Griffiths presented an overview of economic evaluation, defined as the comparative
analysis of alternative interventions in terms of their costs and consequences, which can inform
evidence-based decisions on the most effective way of using scarce resources. Key components
of an economic evaluation are a cost-effectiveness ratio of the incremental cost per outcome
unit that can be used to compare alternative interventions (including the status quo) and a clearly
designed ‘decision analytic model’ by which this ratio can be estimated. Economic evaluations
3

can usually be built into impact evaluations, but have rarely been used when assessing FP/RH
interventions. While the cost-effectiveness of providing FP services to improve maternal health
has been rigorously documented (see presentation by Darroch), decision-makers frequently lack
information on how best to use funds within a FP/RH programme, how interventions are most
efficiently delivered in various settings, and how related services can be cost-effectively
integrated.
Jacqueline Darroch presented the economic evaluation (known as ‘Adding it Up’) that is used by
DFID, USAID, UNFPA, and others to explain the comparative advantage of investing in FP/RH
services [Singh et al.] and to justify such investments to governments and other donors. The
evidence from this analysis has also been used effectively in supporting the rationale for the
FP2020 initiative. The ‘decision analytic model’ for this economic evaluation compares various
scenarios in terms of the impact of meeting women’s needs for contraception on averting
undesired events (e.g. unintended pregnancies, maternal deaths/DALYs, neonatal and infant
deaths) and then estimates the cost per ‘event averted.’

Synthesising and summarising bodies of evidence
Systematic reviews of bodies of evidence are usually considered the highest-ranked methodology
for synthesising evidence of intervention effectiveness (see Hardee) for narrowly defined
measures of impact and for relatively simple interventions that can be feasibly evaluated by an
RCT. As indicated above, RCTs have numerous limitations for evaluating FP/RH interventions,
given their complexity and need to adapt to specific contexts. Rachel Isba described the benefits
and shortcomings of using the standard systematic review process (based on the experiences of
the Cochrane Infectious Diseases Group), and compared this with other review processes
commonly used by DFID, USAID, and others, such as ‘expert reviews’ and ‘structured literature
reviews’. While recognising that systematic reviews synthesise evidence drawn primarily from
RCTs, Isba outlined conditions under which evidence from quasi-experimental and nonrandomised designs could be incorporated into standard systematic reviews, by ensuring that the
risks of bias and confounders are carefully assessed when summarising the findings. The utility of
formal systematic reviews for synthesising evidence of the impact and implementation of FP/RH
interventions stimulated extensive discussion and revealed differences of opinion. The
recommendations presented later represent a meeting consensus, but one that was not
unanimous.
Communicating evidence-informed recommendations to decision-makers needs to be undertaken
carefully, especially when ‘low’-quality evidence supports a ‘strong’ recommendation or ‘high’quality evidence supports a ‘weak’ recommendation. Indeed, the terminology used to describe the
relative ‘strength’ of evidence and of the recommendations that can be made stimulated intense
discussion. Will Evans discussed modalities for summarizing and presenting a body of evidence,
including detailed narratives proposed by DFID for describing the strength of the evidence, and
diagrams that can present evidence strength visually. For DFID, the strength of evidence should
be described and judged in terms of five domains: the size of the body of evidence; its quality; the
context to which the evidence applies; the consistency of the evidence; and the diversity of
research methods on which the evidence is based.
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There are many ways in which a body of evidence can be translated into programmatic
recommendations. Joshua Vogel described the ‘Grading of Recommendations Assessment,
Development and Evaluation’ (GRADE) approach used by WHO, which has two sequential
phases: i) assessing the quality of the evidence (high, moderate, low, very low) in terms of the
extent to which a decision-maker can be confident that an estimate of effect or association is
correct as determined by the methodological quality of evidence and the likelihood of bias (all
evidence from non-RCTs is considered low quality); and ii) the strength of the recommendation
that can be made for or against using the intervention based on this evidence, usually
categorised as strong or weak/ conditional/ qualified. WHO is also using the ‘Developing and
Evaluating Communication Strategies to Support Informed Decisions and Practice Based on
Evidence’ (DECIDE) framework [Vogel, J. et al.] to improve the dissemination of
recommendations developed through GRADE. The framework includes 10 criteria (seriousness
of the problem, number of people affected, quality of the evidence, size of the benefits, size of the
adverse effects, resource use (costs), value for money, impacts on equity, feasibility, and
acceptability) that help determine which health system decisions can be made, by using evidence
to inform judgements about each criterion.
Mary Lyn Gaffield provided further insights into the procedures followed by WHO in developing
practice guidelines, which are defined as any document that contains WHO recommendations
about health interventions. A recommendation “provides information about what policy-makers,
health-care providers or patients should do. It implies a choice between different interventions
that have an impact on health and that have ramifications for the use of resources.” Various types
of guidelines have been developed, all of which have to follow a standard process of
development [WHO 2012] that is managed by a Guideline Development Group, reviewed by an
External Review Group, formulates PICO (population, intervention, comparator, outcome)
questions to be addressed, uses GRADE, and can take 3–37 months.
David Ross described another method for synthesising evidence and developing
recommendations that adapted the principles of systematic review to summarise evidence to
inform specific questions posed by policymakers. This method synthesises evidence from
evaluations of specific interventions designed for particular populations and delivered in defined
contexts. It assumes that different intervention types will need different strengths of evidence in
order to recommend scaling up, and so assesses the evidence in terms of whether it reaches a
particular threshold from which a recommendation can be made. The evidence is reviewed in
relation to a hierarchy of contexts, firstly determining whether there is sufficient evidence of the
intervention’s effect within a specific population group and context, and then assessing evidence
from the intervention in similar populations in other contexts. The strength of evidence available
for each type of intervention / context is then assessed using a hierarchy similar to that outlined
by Hardee, and a decision is made as to whether the threshold of evidence needed for a
recommendation on implementation and scale-up has been reached based on six domains
(feasibility, cost, potential for adverse outcomes, acceptability, potential size of the effect, and
other health or social benefits). Depending on the threshold of evidence reached, the
recommendation is framed as ‘Steady’ (more evidence needed), ‘Ready’ (proceed with careful
M&E), ‘Go’ (proceed with widespread implementation), or ‘Do not go.’
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The fields of implementation science (IS) and health policy and systems research (HPSR) offer
several methodologies that can generate evidence to enable decision-makers to understand why
and how interventions work. Nhan Tran provided an overview of implementation research which
draws on both fields. Health systems are unique and continually changing. Consequently,
intervention implementation is necessarily adaptive, iterative, and dynamic; and decisions need to
be evidence-informed rather than evidence-based, drawing from a range of options and
accounting for factors other than solely research-based evidence. Implementation research is the
scientific study of the processes used in the implementation of interventions as well as the
contextual factors that affect these processes. The evidence generated and summarised is used
to support and promote the effective application and scale-up of interventions that have been
demonstrated to be effective in a range of contexts. The research design and methods used for
implementation research, and thus the quality of evidence generated, depend entirely on the
nature of the implementation question being addressed; Peters et al. provide a review of
approaches used for implementation research. Standards for reporting and publishing
implementation research results have been developed, e.g. SQUIRE [Davidoff et al.], which can
also be used to assess the quality of evidence generated; these focus on clarity of description
and appropriateness of the research for the implementation question being addressed.
Because systematic reviews of RCTs are not necessarily appropriate for informing decisions on
how an FP/RH intervention should best be designed and implemented, alternative approaches
were discussed for synthesising the evidence from implementation research. Marjolein Dieleman
presented the realist synthesis approach, which seeks to understand and summarise what
characteristics of an intervention enable it to work (or not), for whom, and in what circumstances.
A realist synthesis starts by specifying the theory of change that explains how an intervention is
expected to work and assumes that FP/RH interventions may be implemented differently
depending on the context and the implementers. A systematic review process is then followed to
identify and extract evidence from published studies on the intervention. This body of evidence is
analysed by searching for patterns in the way the mechanism functions and the outcomes it
produces in different contexts. The search is guided by the theory of change and results in a
description that incorporates both the outcomes associated with the intervention and how it
functions in various contexts.
A common feature of the various approaches to summarising a body of evidence is the
expectation that decisions should be based on an evidence framework, which uses multiple
domains to arrive at a summary judgement of the evidence. Ian Askew summarised the key
characteristics of a typical evidence framework as being systematic and rigorous, having
transparent procedures to reach a summary judgement, and rating evidence across multiple
domains. A study by Luoto et al., which summarised the same body of evidence using six
different evidence frameworks (including those of the U.S. Community Preventive Services Task
Force, UK National Health Service Health Development Agency, WHO (GRADE), and the
Australian National Health and Medical Research Council), found that the choice of framework
influences the type of recommendations that can be made. While variability in how the
frameworks are applied may influence the evidence summary and recommendations, the choice
of domains included in the framework and how they are rated and weighted are critically
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important, especially for domains relating to implementation, context, and cost. Choice of
domains to include in an evidence framework should be influenced by whether the decision
requires evidence of efficacy (e.g. choice of service delivery intervention), of feasibility and
implementation (e.g. population level impact of a service delivery model), or of sustainability at
scale (e.g. context and cost).

SUMMARY AND RECOMMENDATIONS
Drawing from these presentations, three plenary discussions were held during which participants
sought clarification and critiqued the issues presented. Discussions reflected a diversity of views
on what constitutes high-quality evidence, which type of evidence is appropriate for which type of
recommendations, and which approaches should be followed to translate evidence into practice
recommendations. During each discussion, recommendations were made for consolidating
standards of evidence and formulating guideline recommendations for high-impact practices in
FP/RH programming and policy making as follows:


Suggestions for designing implementation research to maximise the quality of evidence
generated and its utility for decision-making to strengthen reproductive health practices;



Recommendations for rigorously synthesising and grading bodies of evidence;



Proposals to guide appropriate funding and research implementation structures and
procedures to generate strong evidence for practice recommendations in FP/RH.

The recommendations from these discussions are presented below.

Designing implementation research to maximi se the quality of
evidence generated and its utility for decision -making
1. Much of the confusion concerning quality of evidence stems from applying an inappropriate
standard of evidence to a particular research question. Most of the evidence generated and
communicated for guiding FP/RH programming recommendations has sought to answer
questions such as “what works?”, “does this work better than that?”, or “is it safe?”, i.e.
questions of impact, effectiveness, and safety. While questions about intervention
effectiveness are still being asked and require a standard of evidence with high internal
validity, policymakers, programme managers, and funders are increasingly seeking to better
understand how and why an intervention works; to strengthen implementation procedures and
service quality; to determine whether an intervention is acceptable, appropriate, and affordable
for different populations; and to forecast the resources required to sustain and scale-up
effective interventions [Hardee; Cleland].
 Different decisions require different types of evidence generated through
different study designs; consequently the utility of research-based evidence will
depend on its capacity to inform a particular decision.
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2. The highest quality of evidence for evaluating the impact and effectiveness of an
intervention is generated by designs that produce strong internal validity, i.e. which can
demonstrate that an intervention is the only or main cause of the outcomes observed
[Hardee; Hargreaves]. Internal validity is strongest when the research compares the impact
of an intervention on individuals or on ‘clusters’ (groups of individuals or units such as health
facilities) that have been randomly assigned to receive or not receive the intervention, or to
receive different interventions.
 When evaluating impact and effectiveness, and when randomisation does not
compromise the utility of the findings and is affordable, randomisation should be
used to reduce the possibility that factors other than the intervention influence
the outcomes.
3. However, randomisation is generally not feasible if an intervention is complex, if the
implementation site has been pre-determined, or if it would be unethical in certain contexts.
Moreover, implementation may require a specific context that cannot be replicated or scaledup [Campbell]. Furthermore, intervention sites are often intentionally selected by funders,
implementers, and other decision-makers, and so it may not be feasible to randomise study
sites. A range of quasi-experimental / non-randomised designs use different means of
comparison to reduce the threats to internal validity and so can produce high-quality evidence
of intervention effectiveness and impact. Such designs include systematically matching
intervention and comparison populations through use of intervention and control groups,
and/or using statistical adjustments to create an equivalent comparison [Hargreaves].
 Evaluations of intervention effectiveness that cannot randomise the unit of
analysis can instead use systematic comparisons of intervention and control
groups through matching or statistical adjustment to generate high-quality
evidence of impact. Evaluations that use neither randomisation nor systematic
comparison generate lower-quality evidence that should be interpreted with
caution.
4. Designs to evaluate the impact of interventions, especially complex interventions with
multiple outcomes, or to understand implementation procedures, should be guided by an
explicit theory of change (ToC) [Cleland; Campbell]. A ToC should clearly describe an
intervention, how it is expected to influence a change, and the type and level of change that it
can realistically achieve. Impact should also be measured in terms of equity in access to and
use of services among the beneficiaries. A strong ToC also describes the implementation
processes needed for the intervention to achieve the desired outcomes. Without a clear ToC
and a study design to evaluate it, attribution of impact to a particular intervention cannot be
proven.
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 Agreement on the theory of change and alignment of the evaluation design with
the ToC should be reached between the implementing partner, evaluator, and
funder before research is initiated.
5. An economic evaluation measures the costs and cost-effectiveness ratio of
implementation, that is, the incremental cost of achieving the impact by implementing the
intervention compared with the existing service delivery approach and/or with other
comparable interventions; this is usually measured as a cost per outcome unit (e.g. per
unintended pregnancy averted) [Griffiths]. These costs and ratios can then be modelled to
inform decisions on improving implementation efficiencies, forecasting resource needs for
scale-up, and allocating resources between alternative interventions to avert the adverse
events of unintended pregnancy [Darroch]. Incorporating evidence of costs into decisionmaking must be carefully balanced with ensuring that a cost-effective intervention also
reduces inequities.
 Whenever affordable, feasible, and appropriate, an impact evaluation should
include an economic evaluation component so that the feasibility of scale-up and
sustainability of a proven high-impact practice can be determined.
6. When decision-makers need guidance on how a high-impact intervention can be
implemented at scale, evidence can be generated through documenting both the process of
implementation and the contextual factors influencing procedures for intervention
implementation [Campbell; Tran]. Implementation research can provide evidence to inform
guidance for institutionalizing and strengthening an intervention within a health system, for
guiding and assessing quality improvements, and for supporting an intervention’s scale-up
and replication in other systems and contexts.
 Implementation research using mixed-methods design should be used to
generate high-quality evidence describing intervention procedures and context
to inform decisions about scale-up and sustainability; the specific study design
should be determined by the information needed by decision-makers.

Recommendations for synthesising and grading bodies of
evidence on reproductive health
1. Recommendations for guiding decisions on practice effectiveness are based on bodies of
evidence that have been summarised and synthesised and whose findings have been rated
by an expert panel. These processes of summarising and synthesising evidence on practice
effectiveness draw from evidence with high internal validity, including from both randomised
and rigorously implemented comparative non-randomised designs. Non-randomised designs
should specify explicit inclusion and exclusion criteria, specify potential biases and
confounders, and describe the probability of an intervention causing a desired impact [Isba;
Ross].
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 Bodies of evidence that inform decision-makers on the effectiveness of
interventions are best summarised using a transparent, structured review
process that includes evidence from both randomised and rigorous nonrandomised designs with systematic comparisons.
2. Deciding whether to introduce or scale-up an intervention needs to be informed by evidence
other than solely its effectiveness or cost-effectiveness, however. Practice recommendations
for guiding the introduction and scaling up of interventions demonstrated to have high
impact should also be informed by bodies of evidence derived from implementation
research [Tran] that include feasibility, generalizability, and scalability [Ross]. While such
bodies may include evidence from randomised and/or comparative designs, research
methods that describe implementation procedures, and explain them within the context in
which they are operating, usually provide higher-quality evidence for informing such ‘how to’
decisions. A rigorous review process should also be followed to summarise evidence from
implementation research. A realist synthesis [Dieleman] that specifies a ToC and assumes
that FP/RH interventions may be implemented differently depending on the context and the
implementers can provide a structured framework for such reviews.

 Bodies of evidence to inform implementation and scaling-up decisions can be
derived from implementation research and economic evaluations. Highest-quality
data are generated when the decision question is clearly stated and the research
design tailored to generate evidence that will address that question.
 Such bodies of evidence should be guided by a theory of change, reviewed
rigorously, synthesised systematically, and summarised to inform
implementation decisions identified by decision-makers.
3. Summarising the key findings from a body of evidence into recommendations that can be
translated into practice guidelines requires an evidence framework that rates evidence
across multiple domains to arrive at a summary judgement [Askew]. Examples of such
frameworks include GRADE [Vogel], “Steady, Ready, Go!” [Ross], and DFID’s assessment
framework [Evans]. The domains used within an evidence framework will influence the
conclusions that can be drawn and the recommendations than can be made; thus careful
attention must be paid to the configuration and clear explanation of the evidence framework
used.

 A systematic, transparent, and replicable process, guided by an explicit evidence
framework, should be followed when developing practice recommendations from
a body of evidence. The evidence framework should incorporate those domains
that are of specific interest to particular decision-makers; different evidence
frameworks may be appropriate for summarising evidence to inform different
types of decisions.
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4. Great care is needed when interpreting an evidence summary and communicating the
findings through narrative statements or diagrammatically to ensure that the various domains
are clearly described and the rating accurately reflects the available evidence [Evans].
Formulating recommendations is usually undertaken by an expert group or panel that is
convened for the purpose [Malarcher; Gaffield], and that follows systematic, rigorous, and
fully transparent procedures. Communicating recommendations for ‘what’ to do will
necessarily be framed differently than recommendations for ‘how’ to do it.

 Recommendation formulation should be carefully planned and implemented,
using a representative and knowledgeable expert group and recommendation
statements or diagrams that accurately and unequivocally represent the body of
evidence available.
 Given the diversity of contexts in which RH/FP interventions are implemented,
recommendations for implementation should offer a choice of options – that is,
should be ‘evidence-informed’ – rather than specify a single ‘evidence-based’
recommendation for addressing a particular need or problem.

Funding and research implementation structures and procedures
to generate quality evidence and strong recommendations
Panel discussions with representatives from donors (DFID; USAID; Bill and Melinda Gates
Foundation; Packard Foundation; Alliance for Reproductive, Maternal and Newborn Health) and
from research organisations (London School of Hygiene and Tropical Medicine; Population
Council; FHI360; Columbia University; University of North Carolina; University of Ghana; Harvard
University), followed by discussions in plenary, led to the following suggestions:
 External evaluations that separate the roles of donor, implementer, and researcher have
been the norm for most donor-funded impact evaluations. Experience suggests that funding
and designing research on FP/RH interventions so that donors, researchers, and
implementers can work jointly and with complementary roles produces evidence that
is relevant and useful for decision-makers, without compromising the quality of
evidence.
 Challenges encountered when implementing and evaluating interventions, especially
complex interventions, must be documented so that lessons learned from ‘failure’ can
be shared and inform the reconfiguration of an intervention’s structure and
procedures prior to scaling up.
 A decision regarding which research design is most appropriate for generating
evidence to address decision-makers’ specific needs should be made jointly by
donors, researchers, and implementers through a consultative process prior to
initiating research. These consultations should be informed by an awareness of the variety
of designs that can be used, and the type and quality of evidence they can generate.
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 The evidence frameworks for rating evidence used by organisations that set service delivery
and programming norms, and those that fund research and guideline development, vary
considerably. Reducing the variability among and consolidating the key domains and
rating scales used in different evidence frameworks, together with more transparent
evidence review processes, would reduce the likelihood of differing interpretations of
a body of evidence, thereby reinforcing the strength of recommendations.
 As country strategy plans are being reviewed, revised, and costed through initiatives such as
Every Woman, Every Child and FP2020, and investments in large-scale expansion of FP/RH
programme coverage are being made, there are multiple needs and opportunities for highquality evidence on implementation. Donors and researchers should prioritise investment
in and application of implementation research to improve the quality of evidence to
guide rapid scale-up of HIPs and other recommended FP/RH practices.
 Despite decades of investment in building research capacity, a lack of individual and
institutional capacity still exists for undertaking impact evaluations and implementation
research on FP/RH interventions in most developing countries. Donors, governments, and
research organisations should increase investments in a wide range of skills-building
and systems-strengthening activities to enhance and sustain national research
capacities. Priorities should include strengthening HMIS and M&E capacities of service
delivery programmes, building researcher skills in design and analysis methodologies for
generating internally valid data, and intensifying ethical and technical review processes for
national research regulatory bodies.
 Communicating and packaging practice recommendations and guidelines so that they convey
appropriate and valid messages and provide decision-makers with sufficient evidence to
make a particular decision has been challenging. Recommendations on FP/RH
interventions should include guidance on the contexts and populations for which they
may (or may not) be effective and reduce inequities, and on how best to implement
them in such contexts. Recommendations should offer a range of options from which
to choose, so that programming decisions are evidence-informed.
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